Shares of BioNTech soared on Friday following positive results from a key study on its experimental breast cancer treatment. The stock jumped by 10% after the treatment met the predetermined success criteria in the pivotal study. Investors were optimistic about the potential of BioNTech's cancer smart bomb, driving the stock price up significantly. This news was reported by Investor's Business Daily.